Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Investment Tools And Research To Help Make You A More Confident And Profitable Trader. FREE 30 Day Trial
Stocks | Futures | Watchlist | More
or

Promis Neurosciences Inc (PMN.TO)

Promis Neurosciences Inc (PMN.TO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Profile for [[ item.sessionDateDisplayLong ]]

Company Info

Promis Neurosciences Inc 1920 Yonge Street Suite 200 Toronto ON M4S 3E2 CAN

https://www.promisneurosciences.com P: 416-847-6898 F: 415-847-6899

Description:

ProMIS Neurosciences Inc is a clinical-stage biotechnology company focused on generating and developing antibody therapeutics selectively targeting toxic misfolded proteins in neurodegenerative diseases such as Alzheimer's disease (AD), amyotrophic lateral sclerosis (ALS) and multiple system atrophy (MSA). Its proprietary target discovery engine is based on the use of two complementary techniques. The company applies its thermodynamic, computational discovery platform-ProMIS and Collective Coordinates to predict novel targets known as Disease Specific Epitopes on the molecular surface of misfolded proteins.

Key Statistics

Overview:

Market Capitalization, $K 51,476
Shares Outstanding, K 8,579
Annual Sales, $ 0 K
Annual Net Income, $ -13,212 K
Last Quarter Sales, $ 0 K
Last Quarter Net Income, $ -3,580 K
60-Month Beta 0.78
% of Institutional Shareholders 0.01%

Growth:

1-Year Return -16.67%
3-Year Return -51.22%
5-Year Return -72.22%

Per-Share Information:

Most Recent Earnings -0.58 on 05/15/23
Latest Earnings Date 08/11/23
Earnings Per Share ttm -2.70
Dividend Payout Ratio 0.00%
Most Recent Split 1-60 on 06/28/22

PMN.TO Ratios

Ratio
Price/Earnings ttm N/A
Price/Earnings forward N/A
Price/Earnings to Growth N/A
Return-on-Equity % -1,098.51%
Return-on-Assets % -128.63%
Profit Margin % 0.00%
Debt/Equity N/A
Price/Sales N/A
Price/Book N/A
Book Value/Share -0.95
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar